Clarins

Main information

  • Trade name:
  • Clarins Sunscreen Control Cream for the Face SPF50+Very High Protection
  • Medicine domain:
  • Humans
  • Medicine type:
  • Allopathic drug

Documents

Localization

  • Available in:
  • Clarins Sunscreen Control Cream for the Face SPF50+Very High Protection
    Australia
  • Language:
  • English

Other information

Status

  • Source:
  • Dept. of Health,Therapeutic Goods Administration - Australia
  • Authorization number:
  • 218720
  • Last update:
  • 08-10-2017

Public Assessment Report

Public Summary

Summary for ARTG Entry:

218720

Clarins Sunscreen Control Cream for the Face SPF50+Very High Protection

ARTG entry for

Medicine Listed

Sponsor

Trimex Pty Ltd

Postal Address

5 Crewe Place,ROSEBERY, NSW, 2018

Australia

ARTG Start Date

20/12/2013

Product category

Medicine

Status

Active

Approval area

Listed Medicines

Conditions

The sponsor shall keep records relating to this listed medicine as are necessary to: (a) Expedite recall if necessary of any batch of the listed medicine,

(b) Identify the manufacturer(s) of each batch of the listed medicine. Where any part of or step in manufacture in Australia of the listed medicine is

sub-contracted to a third party who is not the sponsor, copies of relevant Good Manufacturing Practice agreements relation to such manufacture shall be

kept.

The sponsor shall retain records of the distribution of the listed medicine for a period of five years and shall provide the records or copies of the records

to the Complementary Medicines Branch, Therapeutic Goods Administration, upon request.

The sponsor of the listed medicine must not, by any means, intentionally or recklessly advertise the medicine for an indication other than those accepted

in relation to the inclusion of the medicine in the Register.

All reports of adverse reactions or similar experiences associated with the use or administration of the listed medicine shall be notified to the Head, Office

of Product Review, Therapeutic Goods Administration, as soon as practicable after the sponsor of the goods becomes aware of those reports. Sponsors

of listed medicines must retain records of such reports for a period of not less than 18 months from the day the Head, Office of Product Review is notified

of the report or reports.

The sponsor shall not supply the listed medicine after the expiry date of the goods.

Where a listed medicine is distributed overseas as well as in Australia, product recall or any other regulatory action taken in relation to the medicine

outside Australia which has or may have relevance to the quality, safety or efficacy of the goods distributed in Australia, must be notified to the National

Manager Therapeutic Goods Administration, immediately the action or information is known to the sponsor.

Products

1. Clarins Sunscreen Control Cream for the Face SPF50+Very High Protection

Product Type

Single Medicine Product

Effective date

20/12/2013

Warnings

Contains phenoxyethanol (or words to that effect).

Wear protective clothing, hats and eyewear when exposed to the sun.[Or words to this effect]

Avoid prolonged exposure in the sun.[or words to that effect]

(If medicine contains one benzoate) Contains [insert name of benzoate] Or (If medicine contains two or more benzoates) Contains benzoates [or words

to that effect].

(If the medicine contains one sorbate) Contains [insert name of sorbate] OR (if medicine contains two or more sorbates) Contains sorbates [or words to

that effect].

Standard Indications

A broad spectrum sunscreening preparation of SPF50+. Can aid in the prevention of sunspots

A broad spectrum sunscreening preparation of SPF50+. May reduce the risk of some skin cancers

A broad spectrum sunscreening preparation of SPF50+. Can aid in the prevention of solar keratoses

Specific Indications

No Specific Indications included on Record

Additional Product information

Container information

Type

Material

Life Time

Temperature

Closure

Conditions

Tube

Not recorded

Not recorded

Not recorded

Not recorded

Not recorded

Pack Size/Poison information

Pack Size

Poison Schedule

Components

1. Formulation 1

Dosage Form

Cream

Route of Administration

Public Summary

Page 1 of

Produced at 26.11.2017 at 04:32:25 AEDT

This is not an ARTG Certificate document.

The onus is on the reader to verify the current accuracy of the information on the document subsequent to the date shown.

Visit www.tga.gov.au for contact information

Topical

Visual Identification

Active Ingredients

butyl methoxydibenzoylmethane

30 mg/g

homosalate

100 mg/g

octocrylene

27 mg/g

octyl salicylate

50 mg/g

oxybenzone

60 mg/g

© Commonwealth of Australia.This work is copyright.You are not permitted to re-transmit, distribute or commercialise the material without obtaining prior

written approval from the Commonwealth.Further details can be found at http://www.tga.gov.au/about/website-copyright.htm.

Public Summary

Page 2 of

Produced at 26.11.2017 at 04:32:25 AEDT

This is not an ARTG Certificate document.

The onus is on the reader to verify the current accuracy of the information on the document subsequent to the date shown.

Visit www.tga.gov.au for contact information